幼年特发性关节炎患者不同疾病病程中新发慢性葡萄膜炎预测模型的开发与外部验证
研究利用国际Pharmachild登记处5393例患者数据开发多变量Cox比例风险模型,预测幼年特发性关节炎(JIA)患儿新发慢性葡萄膜炎,并在英国CAPS和德国ICON两个起始队列中进行外部验证与重新校准;模型纳入JIA发病年龄、ANA阳性及ILAR分类等预测因子,7年葡萄膜炎风险的C统计量在ICON队列为0.75(95%CI 0.72-0.79),在CAPS队列为0.70(95%CI 0.64-0.76),校准良好;作者认为该模型可用于临床告知患者/家长并指导葡萄膜炎筛查频率和关节炎药物选择。
要点
- 模型纳入JIA发病年龄(HR 0.83)、ANA阳性(HR 1.59)和ILAR分类(少关节炎、银屑病关节炎及未分化关节炎 vs 类风湿因子阴性多关节炎 HR 1.40)。
- 重新校准模型在验证队列中表现可接受,7年葡萄膜炎风险C统计量ICON队列0.75(95%CI 0.72-0.79),CAPS队列0.70(95%CI 0.64-0.76)。
- 作者认为该模型可帮助临床医生告知患者/家长并指导葡萄膜炎筛查频率和关节炎药物选择。
核心结论
- 作者首次提出一个经过验证的预后工具,利用常见临床参数即可简单预测个体JIA患者的慢性葡萄膜炎风险。
- 作者认为该模型可被临床医生用于告知患者/家长,并为葡萄膜炎筛查频率和关节炎药物选择提供指导。
研究设计与样本
- 研究使用国际Pharmachild登记处数据开发多变量Cox比例风险模型,预测JIA患儿新发慢性葡萄膜炎。
- 预测因子通过后向选择法筛选,缺失值采用多重插补处理。
- 模型随后在英国儿童关节炎前瞻性研究(CAPS)和德国新诊断幼年特发性关节炎起始队列(ICON)两个起始队列中进行验证和重新校准。
- 模型性能通过校准图和2年、4年、7年葡萄膜炎风险的C统计量评估,并制作了示意图和数字风险计算器供临床使用。
主要发现
- 模型开发共纳入5393例患者,预测变量包括JIA发病年龄(HR 0.83 [95%CI 0.77-0.89])、ANA阳性(HR 1.59 [95%CI 1.06-2.38])和ILAR分类(少关节炎、银屑病关节炎及未分化关节炎 vs 类风湿因子阴性多关节炎 HR 1.40 [95%CI 0.91-2.16])。
- 重新校准的预测模型在验证队列中表现可接受,校准图显示校准良好。
- 7年葡萄膜炎风险的C统计量在ICON队列为0.75(95%CI 0.72-0.79),在CAPS队列为0.70(95%CI 0.64-0.76)。
关键数值与推荐
- JIA发病年龄每增加1岁,新发慢性葡萄膜炎的HR为0.83(95%CI 0.77-0.89)。
- ANA阳性者新发慢性葡萄膜炎的HR为1.59(95%CI 1.06-2.38)。
- 少关节炎、银屑病关节炎及未分化关节炎 vs 类风湿因子阴性多关节炎的新发慢性葡萄膜炎HR为1.40(95%CI 0.91-2.16)。
- 重新校准模型7年葡萄膜炎风险的C统计量:ICON队列0.75(95%CI 0.72-0.79),CAPS队列0.70(95%CI 0.64-0.76)。
临床怎么用
- 作者认为该模型可被临床医生用于告知患者/家长。
- 作者认为该模型可为葡萄膜炎筛查频率提供指导。
- 作者认为该模型可为关节炎药物选择提供指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and externally validate a prediction model for new-onset chronic uveitis in children with juvenile idiopathic arthritis (JIA) for clinical application. METHODS: Data from the international Pharmachild registry were used to develop a multivariable Cox proportional hazards model. Predictors were selected by backward selection, and missing values were handled by multiple imputation. The model was subsequently validated and recalibrated in 2 inception cohorts: the UK Childhood Arthritis Prospective Study (CAPS) study and the German Inception Cohort of Newly diagnosed patients with juvenile idiopathic arthritis (ICON) study. Model performance was evaluated by calibration plots and C statistics for the 2-, 4-, and 7-year risk of uveitis. A diagram and digital risk calculator were created for use in clinical practice. RESULTS: A total of 5,393 patients were included for model development, and predictor variables were age at JIA onset (hazard ratio [HR] 0.83 [95% confidence interval (95% CI) 0.77-0.89]), ANA positivity (HR 1.59 [95% CI 1.06-2.38]), and International League of Associations for Rheumatology category of JIA (HR for oligoarthritis, psoriatic arthritis, and undifferentiated arthritis versus rheumatoid factor-negative polyarthritis 1.40 [95% CI 0.91-2.16]). Performance of the recalibrated prediction model in the validation cohorts was acceptable; calibration plots indicated good calibration and C statistics for the 7-year risk of uveitis (0.75 [95% CI 0.72-0.79] for the ICON cohort and 0.70 [95% CI 0.64-0.76] for the CAPS cohort). CONCLUSION: We present for the first time a validated prognostic tool for easily predicting chronic uveitis risk for individual JIA patients using common clinical parameters. This model could be used by clinicians to inform patients/parents and provide guidance in choice of uveitis screening frequency and arthritis drug therapy.
引用
- van Straalen JW, Kearsley-Fleet L, Klotsche J, et al. Development and External Validation of a Model Predicting New-Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2022. PMID: 36054539. doi:10.1002/art.42329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。